Our top pick for
Mobile users
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy ACADIA Pharmaceuticals stock | 41.49
Own ACADIA Pharmaceuticals stock in just a few minutes.
ACADIA Pharmaceuticals Inc is a biotechnology business based in the US. ACADIA Pharmaceuticals shares (ACAD) are listed on the NASDAQ and all prices are listed in US Dollars. ACADIA Pharmaceuticals employs 580 staff and has a trailing 12-month revenue of around USD$419.1 million.
How to buy shares in ACADIA Pharmaceuticals
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for ACADIA Pharmaceuticals. Find the stock by name or ticker symbol: ACAD. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until ACADIA Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of USD$41.49, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of ACADIA Pharmaceuticals, depending on your broker.
- Check in on your investment. Congratulations, you own a part of ACADIA Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
How has coronavirus impacted ACADIA Pharmaceuticals's share price?
Since the stock market crash in March caused by coronavirus, ACADIA Pharmaceuticals's share price has had significant negative movement.
Its last market close was USD$41.49, which is 8.07% down on its pre-crash value of USD$45.13 and 38.21% up on the lowest point reached during the March crash when the shares fell as low as USD$30.02.
If you had bought USD$1,000 worth of ACADIA Pharmaceuticals shares at the start of February 2020, those shares would have been worth USD$855.75 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,014.43.
ACADIA Pharmaceuticals share price
Use our graph to track the performance of ACAD stocks over time.ACADIA Pharmaceuticals shares at a glance
Information last updated 2020-11-27.
| Latest market close | USD$41.49 |
|---|---|
| 52-week range | USD$30.02 - USD$58.72 |
| 50-day moving average | USD$47.4933 |
| 200-day moving average | USD$45.7681 |
| Wall St. target price | USD$59.61 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-1.966 |
Buy ACADIA Pharmaceuticals shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ACADIA Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ACADIA Pharmaceuticals price performance over time
Historical closes compared with the close of $41.49 from 2020-10-19
| 1 week (2020-11-24) | -24.18% |
|---|---|
| 1 month (2020-10-30) | -10.68% |
| 3 months (2020-09-01) | 8.95% |
| 6 months (2020-06-01) | -15.14% |
| 1 year (2019-11-29) | -8.39% |
|---|---|
| 2 years (2018-11-30) | 117.68% |
| 3 years (2017-12-01) | 37.57% |
| 5 years (2015-12-01) | 10.61% |
ACADIA Pharmaceuticals financials
| Revenue TTM | USD$419.1 million |
|---|---|
| Gross profit TTM | USD$79.1 million |
| Return on assets TTM | -17.86% |
| Return on equity TTM | -39.86% |
| Profit margin | -63.92% |
| Book value | $4.122 |
| Market capitalisation | USD$8.9 billion |
TTM: trailing 12 months
Shorting ACADIA Pharmaceuticals shares
There are currently 8.8 million ACADIA Pharmaceuticals shares held short by investors – that's known as ACADIA Pharmaceuticals's "short interest". This figure is 0.6% down from 8.9 million last month.
There are a few different ways that this level of interest in shorting ACADIA Pharmaceuticals shares can be evaluated.
ACADIA Pharmaceuticals's "short interest ratio" (SIR)
ACADIA Pharmaceuticals's "short interest ratio" (SIR) is the quantity of ACADIA Pharmaceuticals shares currently shorted divided by the average quantity of ACADIA Pharmaceuticals shares traded daily (recently around 1.2 million). ACADIA Pharmaceuticals's SIR currently stands at 7.46. In other words for every 100,000 ACADIA Pharmaceuticals shares traded daily on the market, roughly 7460 shares are currently held short.
However ACADIA Pharmaceuticals's short interest can also be evaluated against the total number of ACADIA Pharmaceuticals shares, or, against the total number of tradable ACADIA Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ACADIA Pharmaceuticals's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 ACADIA Pharmaceuticals shares in existence, roughly 50 shares are currently held short) or 0.0877% of the tradable shares (for every 100,000 tradable ACADIA Pharmaceuticals shares, roughly 88 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against ACADIA Pharmaceuticals.
Find out more about how you can short ACADIA Pharmaceuticals stock.
ACADIA Pharmaceuticals share dividends
We're not expecting ACADIA Pharmaceuticals to pay a dividend over the next 12 months.
ACADIA Pharmaceuticals share price volatility
Over the last 12 months, ACADIA Pharmaceuticals's shares have ranged in value from as little as $30.02 up to $58.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ACADIA Pharmaceuticals's is 1.4267. This would suggest that ACADIA Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
ACADIA Pharmaceuticals overview
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia that are in Phase III clinical trials; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Frequently asked questions
More guides on Finder
-
How to buy Chase Corporation stock
Steps to owning and managing CCF, with 24-hour and historical pricing before you buy.
-
How to buy CDW Corporation stock | 139.08
Steps to owning and managing CDW, with 24-hour and historical pricing before you buy.
-
How to buy Camping World stock
Steps to owning and managing CWH, with 24-hour and historical pricing before you buy.
-
How to buy Catalyst Biosciences stock
Steps to owning and managing CBIO, with 24-hour and historical pricing before you buy.
-
How to buy Bridgeline Digital stock
Steps to owning and managing BLIN, with 24-hour and historical pricing before you buy.
-
How to buy Calavo Growers stock | 72.77
Steps to owning and managing CVGW, with 24-hour and historical pricing before you buy.
-
How to buy Aegion Corporation stock | 15.82
Steps to owning and managing AEGN, with 24-hour and historical pricing before you buy.
-
How to buy Arthur JGallagher-and-Co stock
Steps to owning and managing AJG, with 24-hour and historical pricing before you buy.
-
How to buy ABB stock
Steps to owning and managing ABB, with 24-hour and historical pricing before you buy.
-
How to buy Youngevity International stock
Steps to owning and managing YGYI, with 24-hour and historical pricing before you buy.
Ask an Expert